These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 19947055

  • 1. Upfront intraperitoneal chemotherapy for patients with epithelial ovarian cancer: long-term follow-up of a previously published trial.
    Del Prete SA, Ruppel MC, Hinchey JM, Del Prete CJ, Weinstein PL.
    Conn Med; 2009; 73(10):581-3. PubMed ID: 19947055
    [Abstract] [Full Text] [Related]

  • 2. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S, Yeap B, Vogl S, Carbone P.
    Cancer; 1996 Feb 15; 77(4):733-42. PubMed ID: 8616766
    [Abstract] [Full Text] [Related]

  • 3. Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up.
    Morgan RJ, Braly P, Cecchi G, Leong L, Shibata S, Margolin K, Somlo G, McNamara M, Longmate J, Schinke S, Raschko J, Nagasawa S, Kogut N, Parker P, Stein A, Cho J, Smith E, Coluzzi P, Najera L, Johnson D, Womack E, Doroshow JH.
    Gynecol Oncol; 1999 Dec 15; 75(3):419-26. PubMed ID: 10600300
    [Abstract] [Full Text] [Related]

  • 4. Epithelial ovarian cancer treated by platinum or platinum analogue with cyclophosphamide: experience in Ramathibodi Hospital.
    Linasmita V, Wilailak S, Srisupundit S, Tangtrakul S, Bullangpoti S, Israngura N.
    J Med Assoc Thai; 1998 Jan 15; 81(1):10-6. PubMed ID: 9470316
    [Abstract] [Full Text] [Related]

  • 5. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
    Skarlos DV, Aravantinos G, Kosmidis P, Athanassiadis A, Stathopoulos GP, Pavlidis N, Bafaloukos D, Karphathios S, Papakostas P, Bamia C, Fountzilas G.
    Semin Oncol; 1997 Oct 15; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
    [Abstract] [Full Text] [Related]

  • 6. The optimal debulking after neoadjuvant chemotherapy in ovarian cancer: proposal based on interval look during upfront surgery setting treatment.
    Onda T, Yoshikawa H, Yasugi T, Matsumoto K, Taketani Y.
    Jpn J Clin Oncol; 2010 Jan 15; 40(1):36-41. PubMed ID: 19820253
    [Abstract] [Full Text] [Related]

  • 7. Meta-analysis of cisplatin, doxorubicin, and cyclophosphamide versus cisplatin and cyclophosphamide chemotherapy of ovarian carcinoma.
    Fanning J, Bennett TZ, Hilgers RD.
    Obstet Gynecol; 1992 Dec 15; 80(6):954-60. PubMed ID: 1333066
    [Abstract] [Full Text] [Related]

  • 8. Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up.
    Morgan RJ, Braly P, Leong L, Shibata S, Margolin K, Somlo G, McNamara M, Longmate J, Schinke S, Raschko J, Nagasawa S, Kogut N, Najera L, Johnson D, Doroshow JH.
    Gynecol Oncol; 2000 Jun 15; 77(3):433-8. PubMed ID: 10831355
    [Abstract] [Full Text] [Related]

  • 9. [Comparative study of different chemotherapy approaches for advanced epithelial ovarian cancer].
    Chen YL, Liu YQ, Tang DH, Chu CN.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb 15; 43(2):110-4. PubMed ID: 18683749
    [Abstract] [Full Text] [Related]

  • 10. Intraperitoneal cisplatin-based chemotherapy for primary treatment of epithelial ovarian cancer.
    Del Prete SA, Ryan SP, Nelson JH.
    Conn Med; 2001 Feb 15; 65(2):71-5. PubMed ID: 11265604
    [Abstract] [Full Text] [Related]

  • 11. Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest.
    Gadducci A, Carnino F, Chiara S, Brunetti I, Tanganelli L, Romanini A, Bruzzone M, Conte PF.
    Gynecol Oncol; 2000 Feb 15; 76(2):157-62. PubMed ID: 10637064
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Identification of prognostic factors after positive second-look surgery in epithelial ovarian carcinoma.
    McCreath WA, Eisenhauer EL, Abu-Rustum NR, Venkatraman ES, Caceres A, Bier R, Huh J, Cho J, Barakat RR, Chi DS.
    Gynecol Oncol; 2006 Jul 15; 102(1):8-14. PubMed ID: 16427689
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.